Flying L Partners
Private equityLate Stage · 5 people tracked
Investment thesis
Flying L Partners is a partnership of experienced colleagues focused on driving innovation in the ophthalmic sector and generating value for investors. Its strategy is opportunity-driven: the firm first identifies a promising company, then raises capital specifically to invest in that opportunity, rather than deploying from a pre-committed blind pool. After investing, the partners engage deeply with the company to accelerate its progress, keeping a tight focus on innovation in eye care and related technologies.
Source: firm website, verified Aug 3, 2026.
Team · 5 people
from the firm's websiteWhat they invest in
from 8 of 10 portfolio companiesHealthtech ×6Biotech ×5Medical Devices ×4
HQs:United States×6
Investments · 10 tracked
founders shown can be your intro pathRxSight develops the Light Adjustable Lens (LAL), an FDA-approved intraocular lens that surgeons can adjust after cataract surgery to fine-tune a patient's prescription once the eye has healed.
HealthtechMedical DevicesPasadena, US
Joseph Devivo(Director)James N. Adler(Director)Robert H. Grubbs(Director)Werner F. Wolfen(Director)D. Verne Sharma(Executive Officer, Director)Javier Perez-Sala(Director)
Co-investorsForesite CapitalH.I.G. CapitalH.I.G. HealthBridge PartnersLongitude CapitalRA CapitalVisionary Ventures+1 more
Tarsus Rx is a pharmaceutical company developing treatments for diseases with high unmet need, with a lead product XDEMVY (lotilaner ophthalmic solution) approved by the FDA for Demodex blepharitis.
BiotechHealthtechMedical Devices
Bobak Azamian, MD, PhD(Founder)in
Co-investorsAPERTURE Venture PartnersFrazier Life SciencesVisionary VenturesVivo Capital
BiotechIrvine, US
Alan Waterhouse(President and Chief Operating Officer)Jason Tester(Chief Financial Officer and Secretary)James V. Mazzo(President, Chief Executive Officer and Chairman of the Board)Ryan M. Schwarz(Director)Charles Warden(Director)Charles Larsen(Director)
Co-investorsEvidity Health CapitalVersant Venture AIV Holdings
Aurion Biotech develops regenerative cell therapies for ophthalmology, focused on treating blindness and vision loss from corneal endothelial disease.
BiotechHealthtechMedical DevicesSeattle, US
DAVID ROSTOV(Executive Officer)GREG KUNST(Executive Officer, Director)PATRICK LALLY(Director)JEANNETTE BANKES(Director)CHRISTINE MCCAULEY(Director)ARNAUD LACOSTE(Executive Officer)
Co-investorsVisionary VenturesDeerfield Management Company
Co-investorsVisionary Ventures
HealthtechSioux Falls, US
TYLER STOWATER(Director)JOHN BERDAHL(Executive Officer, Director)JEFFRY WEINHUFF(Director)
BoardRICHARD LINDSTROM(Director)J. ANDY CORLEY(Director)
Co-investorsVersant Venture AIV Holdings
Neurolens makes therapeutic eyeglass lenses with patented Contoured Prism technology and a measurement device that customizes prescriptions to reduce symptoms of eye misalignment such as headaches, neck pain, motion sickness, and eye strain.
HealthtechMedical Devices
A healthcare company that develops and supplies medicines, including new and more affordable therapies, aiming for reliable supply of needed treatments.
BiotechHealthtechSan Francisco, US
Jeffrey Nau(Executive Officer, Director)Mark A. Murray(Executive Officer, Director)D. Michael Ackermann(Director)
BoardWilliam J Link(Director)Ali Behbahani(Director)in
Co-investorsNew Enterprise Associates (NEA)Versant Venture AIV Holdings
Co-investorsVisionary Ventures
BiotechCopley, US
Kevin Hershfield(Executive Officer, Director)
BoardWilliam Link(Director)Jeffry Weinhuff(Director)Tyler Stowater(Director)Richard Heinick(Director)Steve Pazol(Director)
Co-investorsVisionary VenturesVersant Venture AIV Holdings
Exits · 2
IPOs and acquisitions across the tracked portfolioRxsightNASDAQ: RXSTTarsus PharmaceuticalsNASDAQ: TARS
Portfolio news
latest coverage across their companies
Aurion Biotech · regmednet.com · Aug 20, 2026
Rxsight · tipranks.com · Aug 12, 2026
Frequently asked questions
- How many investments has Flying L Partners made?
- Flying L Partners has 9 tracked investments.
- What stage does Flying L Partners invest at?
- Flying L Partners invests at the Late Stage stage.
- What sectors does Flying L Partners focus on?
- Flying L Partners focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Who does Flying L Partners co-invest with?
- Flying L Partners most often shares deals with Visionary Ventures, Foresite Capital, Longitude Capital, among 11 tracked co-investors.
Similar investors
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Eight Roads Ventures is a venture capital firm that backs and partners with technology and healthcare companies.
GV (Google Ventures) is a venture capital firm that has invested in artificial intelligence and machine learning since its early days, building a global portfolio of more than 100 AI companies across infrastructure, life sciences, and applications.
Khosla Ventures is a venture capital firm that invests in early-stage companies focused on technology, mobile, and clean energy sectors, including biotechnology applications. The firm provides capital and strategic support to entrepreneurs developing breakthrough technologies across multiple markets.